DPP4 and neoplasm: In addition to detecting CD26 expression on tumor cells or lymphocytes prior to the therapeutic administration of humanized anti-CD26 mAb, it is also important to evaluate whether anti-CD26 mAb therapy affects CD26 expression on relevant tissues.